Who Dominates the Medical Inhaled Nitric Oxide Market? Top Players Revealed According to a newly published market research report by 24LifeSciences, global Medical Inhaled Nitric Oxide market was valued at USD 1.14 billion in 2024 and is projected to reach USD 2.14 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3732/medical-inhaled-nitric-oxide-market

T-Cell Bispecific Antibodies Market Analysis 2032 | Regional Insights According to a newly published market research report by 24LifeSciences, Global T-cell Bispecific Antibodies Drug Market was valued at USD 856 million in 2024 and is projected to reach USD 9672 million by 2031, growing at a compound annual growth rate (CAGR) of 42.4% during the forecast period 2025–2031. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3447/t-cell-bispecific-antibodies-drug-market

Global Calcineurin Inhibitor Drug Market Forecast 2026: Revenue Insights According to a newly published market research report by 24LifeSciences, global calcineurin inhibitor drug market was valued at USD 7.2 billion in 2024 and is projected to grow to USD 9.8 billion by 2032, registering a compound annual growth rate (CAGR) of 3.5% during the forecast period 2025-2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/12198/calcineurin-inhibitor-drug-market

Synthetic Artificial Blood Vessels Market to Grow at 8.2% CAGR Through 2032 According to a newly published market research report by 24LifeSciences, global synthetic artificial blood vessels market was valued at USD 2.8 billion in 2024 and is projected to reach USD 5.4 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11544/synthetic-artificial-blood-vessels-market

Top 10 Companies Leading the Blood Component Extractors Market Growth According to a newly published market research report by 24LifeSciences, global automatic blood component extractors market was valued at USD 380 million in 2024 and is projected to reach USD 620 million by 2032, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period 2025-2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10934/automatic-blood-component-extractors-market

What Is the Future of the Procalcitonin Antibody Market? 2025–2032 Outlook According to a newly published market research report by 24LifeSciences, global procalcitonin antibody market was valued at USD 280 million in 2024 and is projected to reach USD 450 million by 2032, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11050/procalcitonin-antibody-market

Global Neonatal Critical Care Equipment Market to Reach USD 2.18 Billion by 2032 According to a newly published market research report by 24LifeSciences, global neonatal critical care equipment market was valued at USD 1.42 billion in 2024 and is projected to reach USD 2.18 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period 2025-2032. Neonatal critical care equipment comprises specialized medical devices designed for the care of newborn infants, particularly those born prematurely or with life-threatening conditions. This equipment is fundamental to the function of a Neonatal Intensive Care Unit (NICU) and includes categories such as thermoregulation devices (incubators and warmers), phototherapy units for treating jaundice, advanced monitoring systems for tracking vital signs, and respiratory support equipment like ventilators and CPAP devices. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11576/neonatal-critical-care-equipment-market

UV Disinfection Nucleic Acid Extraction Market Size & Share Analysis 2034 According to a newly published market research report by 24LifeSciences, global UV Disinfection Nucleic Acid Extraction System market was valued at USD 694 million in 2024 and is projected to reach USD 961 million by 2031, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period 2024–2031. UV Disinfection Nucleic Acid Extraction Systems are advanced laboratory instruments that integrate ultraviolet light technology for sterilization and decontamination alongside nucleic acid extraction. These systems simultaneously extract nucleic acids from biological samples while using UV-C light at 254 nm wavelength to eliminate contaminants on instrument surfaces and workspaces, thereby minimizing cross-contamination risks and ensuring high-purity results essential for molecular diagnostics and research applications. These systems have become vital for laboratories handling infectious materials, supporting critical processes like virus detection, genotyping, PCR preparation, and genomic research while maintaining the highest standards of biosafety and sample integrity. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/2567/uv-disinfection-nucleic-acid-extraction-system-market

Top 10 Companies Leading the Platelet-Rich Plasma Market Growth According to a newly published market research report by 24LifeSciences, Global Platelet Rich Plasma (PRP) Market was valued at USD 333 million in 2024 and is projected to reach USD 728 million by 2032, growing at a compound annual growth rate (CAGR) of 12.1% during the forecast period 2025-2032. Platelet Rich Plasma (PRP) is a concentrated autologous blood product containing high levels of platelets and growth factors, derived through centrifugation of whole blood. PRP therapy harnesses the body's natural healing mechanisms to promote tissue regeneration, making it valuable in orthopedic, cosmetic, and dental applications. Its established efficacy in accelerating healing continues to underpin its importance in regenerative medicine and minimally invasive treatments. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/1765/platelet-rich-plasma-prp-market

What Is the Future of the Newborn Screening Program Market? 2025–2032 Outlook According to a newly published market research report by 24LifeSciences, global newborn screening program market was valued at USD 629 million in 2024 and is projected to reach USD 750 million by 2032, growing at a compound annual growth rate (CAGR) of 2.6% during the forecast period. Newborn screening represents a cornerstone of pediatric preventive healthcare, involving the systematic testing of infants shortly after birth to identify congenital disorders that may not be immediately apparent. These programs utilize a heel-prick blood sample to detect conditions such as hypothyroidism, phenylketonuria, galactosemia, and sickle cell disease through advanced methodologies like tandem mass spectrometry and enzymatic assays. The fundamental purpose is to enable timely medical interventions that can prevent severe health complications, disability, or even death, thereby significantly improving long-term outcomes for affected children. While global adoption continues to grow, propelled by rising awareness and mandatory policies in numerous countries, the market still contends with challenges including regional disparities in implementation and the ongoing need for technological advancement in diagnostic capabilities. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/2231/newborn-screening-program-market

Rapid Drug Testing Kit Market Outlook: Opportunities & Trends According to a newly published market research report by 24LifeSciences, global Rapid Drug Testing Kit market was valued at USD 5.681 billion in 2024 and is projected to reach USD 10.66 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period. A rapid drug testing kit is a portable and user-friendly medical diagnostic device designed for the immediate, on-site detection of drugs or their metabolites in biological samples like urine, saliva, or oral fluids. This essential tool provides crucial results within minutes, cementing its indispensable role across workplace safety programs, law enforcement operations, and clinical healthcare settings. The market is propelled by stricter regulatory mandates, growing awareness of substance abuse's societal impact, and continuous technological enhancements that improve both accuracy and accessibility. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/2352/rapid-drug-testing-kit-market

Who Dominates the Iodine Contrast Media Market? Top Players Revealed According to a newly published market research report by 24LifeSciences, global iodine contrast media market was valued at USD 3613 million in 2024 and is projected to reach USD 4963 million by 2031, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period. Iodinated contrast media are radiographic contrast agents containing iodine atoms that enhance the visibility of internal structures in medical imaging procedures. They are primarily used in computed tomography (CT) scans but also find application in fluoroscopy, angiography, venography, and occasionally plain radiography. Their established efficacy in providing clear, high-resolution images continues to underpin their critical importance in modern diagnostic medicine and interventional radiology. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3555/iodine-contrast-media-market